Treatment of lipodermatosclerosis with oxandrolone in a patient with stanozolol-induced hepatotoxicity

J Am Acad Dermatol. 2000 Sep;43(3):558-9. doi: 10.1067/mjd.2000.106517.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anabolic Agents / adverse effects*
  • Anabolic Agents / therapeutic use
  • Chemical and Drug Induced Liver Injury*
  • Female
  • Humans
  • Hyperpigmentation / etiology
  • Hyperpigmentation / pathology*
  • Middle Aged
  • Oxandrolone / therapeutic use*
  • Scleroderma, Localized / drug therapy*
  • Scleroderma, Localized / pathology
  • Stanozolol / adverse effects*
  • Stanozolol / therapeutic use
  • Venous Insufficiency / complications*

Substances

  • Anabolic Agents
  • Stanozolol
  • Oxandrolone